Skip to main content
OpenTrials
Completed

NCT Number: NCT03190161

Music to Reduce Use of Smoking in Patients With Schizophrenia

The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder who smoke/nicotine will participate in an individual session of self-selected music listening for a half an hour.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Behavior Chemically-Induced Disorders Mental Disorders Nicotine Dependence Schizophrenia Spectrum and Other Psychotic Disorders Smoking Smoking, Tobacco Substance-Related Disorders Tobacco Smoking Tobacco Use Tobacco Use Disorder

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New York University School of Medicine

New York, 10016, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • clinician verification diagnosis of Schizophrenia or Schizoaffective Disorder
  • smoked at least 10 cigarettes per day for the past month
  • score of 4 or more on the Fagerstrom Test for Nicotine Dependence73
  • psychiatric stability (e.g., no psychiatric hospitalizations within the last year, no expectation for medication change during study participation, no active suicidal ideation, no symptoms that interfere with ability to participate in study activities)
  • the capacity to participate in the informed consent process

Exclusion criteria

  • being medically unstable (e.g., medical condition that requires frequent medical appointments or hospitalizations and interferes with ability to participate in study activities)
  • report active substance abuse or testing positive drug or alcohol use
  • taking bupropion, varenicline, nicotine replacement products and/or involved in any other smoking cessation treatment
  • participating in any treatment or activity that includes music as a focus
  • having a seizure disorder, other neurological illnesses, or a family history of seizures

Treatment and study plan

Music session

Behavioral

Participants will be asked to refrain from smoking from 24 hours before the music listening session as confirmed by breath carbon monoxide level <6 ppm on the day of the session. They will be contacted by phone or in person at the clinic as a reminder prior.

Primary outcomes

  1. Snaith-Hamilton Pleasure Scale (SHAPS)

    Time frame: 1 Day

    Measures Pleasure Pre Music Session

  2. Snaith-Hamilton Pleasure Scale (SHAPS) Post Music Session

    Time frame: 1 Day

    Measures Pleasure Post Music Session

  3. Pleasure Rating Scale (PRS)

    Time frame: 1 Day

    Measures Pleasure Pre Music Session

  4. Pleasure Rating Scale (PRS) Post Music Session

    Time frame: 1 Day

    Measures Pleasure Post Music Session

  5. Questionnaire of Smoking Urges-Brief (QSU-B)

    Time frame: 1 Day

    Measures Cravings Pre Music Session

  6. Questionnaire of Smoking Urges-Brief (QSU-B) Post Music Session

    Time frame: 1 Day

    Measures Cravings Post Music Session

  7. Minnesota Nicotine Withdrawal Scale (MNWS)

    Time frame: 1 Day

    Measures Withdrawal Pre Music Session and Post Music Session

  8. Minnesota Nicotine Withdrawal Scale (MNWS) Post Music Session

    Time frame: 1 Day

    Measures Withdrawal Post Music Session

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jun 16, 2017
Registry last updated
Aug 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.